Corrective and Preventive Actions (CAPA) In Pharmaceuticals
In pharmaceuticals research, production and marketing there may be errors from the human side or due to machine error. Despite […]
Global Regulations on Nitrosamines in Pharmaceuticals
Despite the considerable efforts invested by global regulatory authorities in evaluating the safety and efficacy of drugs for their citizens,
Why Pharma Companies Must Use Contingent Regulatory Contract Staffing Services
The pharmaceutical industry is highly regulated, and companies must comply with a complex web of regulations in order to bring
Artificial Intelligence (AI) and Machine Learning (ML) in Drug Discovery
Artificial Intelligence (AI) and Machine Learning (ML) in drug discovery offer new possibilities for accelerating the drug development and improving
Global Drug Approval Process: Key Steps & Tips to Expedite Approval
Drugs are marketed only after their approval by regulatory authority. Only safe, effective and medicines of quality are approved by
Artificial Intelligence Impact on Global Pharma Regulatory Affairs
Artificial Intelligence (AI) has been making significant strides across various sectors, and the pharma industry is no exception. One area
COFEPRIS Regulation of Nitrosamines in Pharmaceuticals in Mexico
Nitrosamines have emerged as a significant concern in the pharmaceutical industry due to their potential carcinogenic effects. As impurities that
Digital Health In Regulatory Affairs
The old traditional methods of diagnosis, treatment and prevention have certain drawbacks such as late detection of non-symptomatic diseases, lesser
Pharmacovigilance of Vaccines in the USA (US FDA)
Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other